CA2790257C - Implant cannula having an implant and method for securing implants in an injection cannula - Google Patents
Implant cannula having an implant and method for securing implants in an injection cannula Download PDFInfo
- Publication number
- CA2790257C CA2790257C CA2790257A CA2790257A CA2790257C CA 2790257 C CA2790257 C CA 2790257C CA 2790257 A CA2790257 A CA 2790257A CA 2790257 A CA2790257 A CA 2790257A CA 2790257 C CA2790257 C CA 2790257C
- Authority
- CA
- Canada
- Prior art keywords
- implant
- cannula
- injection
- injection cannula
- physiologically tolerable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000007943 implant Substances 0.000 title claims abstract description 236
- 238000002347 injection Methods 0.000 title claims abstract description 102
- 239000007924 injection Substances 0.000 title claims abstract description 102
- 238000000034 method Methods 0.000 title claims abstract description 33
- 239000000463 material Substances 0.000 claims description 130
- 230000009969 flowable effect Effects 0.000 claims description 51
- 239000004480 active ingredient Substances 0.000 claims description 35
- 229920000642 polymer Polymers 0.000 claims description 35
- 239000002861 polymer material Substances 0.000 claims description 34
- 229920003023 plastic Polymers 0.000 claims description 20
- 239000004033 plastic Substances 0.000 claims description 20
- 239000012056 semi-solid material Substances 0.000 claims description 19
- 229920001577 copolymer Polymers 0.000 claims description 11
- BLCLNMBMMGCOAS-URPVMXJPSA-N Goserelin Chemical compound C([C@@H](C(=O)N[C@H](COC(C)(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1[C@@H](CCC1)C(=O)NNC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 BLCLNMBMMGCOAS-URPVMXJPSA-N 0.000 claims description 10
- 108010069236 Goserelin Proteins 0.000 claims description 10
- 239000003814 drug Substances 0.000 claims description 10
- 229960002913 goserelin Drugs 0.000 claims description 10
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 claims description 8
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 8
- DEQANNDTNATYII-OULOTJBUSA-N (4r,7s,10s,13r,16s,19r)-10-(4-aminobutyl)-19-[[(2r)-2-amino-3-phenylpropanoyl]amino]-16-benzyl-n-[(2r,3r)-1,3-dihydroxybutan-2-yl]-7-[(1r)-1-hydroxyethyl]-13-(1h-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxa Chemical compound C([C@@H](N)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC=2C3=CC=CC=C3NC=2)NC(=O)[C@H](CC=2C=CC=CC=2)NC1=O)C(=O)N[C@H](CO)[C@H](O)C)C1=CC=CC=C1 DEQANNDTNATYII-OULOTJBUSA-N 0.000 claims description 5
- 108010000817 Leuprolide Proteins 0.000 claims description 5
- 108010016076 Octreotide Proteins 0.000 claims description 5
- GFIJNRVAKGFPGQ-LIJARHBVSA-N leuprolide Chemical compound CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)CC1=CC=C(O)C=C1 GFIJNRVAKGFPGQ-LIJARHBVSA-N 0.000 claims description 5
- 229960004338 leuprorelin Drugs 0.000 claims description 5
- 229960002700 octreotide Drugs 0.000 claims description 5
- 229920000747 poly(lactic acid) Polymers 0.000 claims description 5
- YBBLVLTVTVSKRW-UHFFFAOYSA-N anastrozole Chemical compound N#CC(C)(C)C1=CC(C(C)(C#N)C)=CC(CN2N=CN=C2)=C1 YBBLVLTVTVSKRW-UHFFFAOYSA-N 0.000 claims description 4
- 229960002932 anastrozole Drugs 0.000 claims description 4
- 235000014655 lactic acid Nutrition 0.000 claims description 4
- 239000004310 lactic acid Substances 0.000 claims description 4
- RAPZEAPATHNIPO-UHFFFAOYSA-N risperidone Chemical compound FC1=CC=C2C(C3CCN(CC3)CCC=3C(=O)N4CCCCC4=NC=3C)=NOC2=C1 RAPZEAPATHNIPO-UHFFFAOYSA-N 0.000 claims description 4
- 229960001534 risperidone Drugs 0.000 claims description 4
- -1 for example Substances 0.000 description 21
- 238000002513 implantation Methods 0.000 description 18
- 239000000203 mixture Substances 0.000 description 17
- 229920001223 polyethylene glycol Polymers 0.000 description 14
- 239000011159 matrix material Substances 0.000 description 13
- 239000000243 solution Substances 0.000 description 11
- 229920006324 polyoxymethylene Polymers 0.000 description 9
- 229920001296 polysiloxane Polymers 0.000 description 9
- 239000002904 solvent Substances 0.000 description 9
- 239000007787 solid Substances 0.000 description 7
- 229930040373 Paraformaldehyde Natural products 0.000 description 6
- 229920002565 Polyethylene Glycol 400 Polymers 0.000 description 6
- 229920006238 degradable plastic Polymers 0.000 description 6
- 241001631457 Cannula Species 0.000 description 5
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 5
- 229910000831 Steel Inorganic materials 0.000 description 5
- 229920002523 polyethylene Glycol 1000 Polymers 0.000 description 5
- 229920002379 silicone rubber Polymers 0.000 description 5
- 239000010959 steel Substances 0.000 description 5
- 238000004659 sterilization and disinfection Methods 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 150000004665 fatty acids Chemical class 0.000 description 4
- 150000002191 fatty alcohols Chemical class 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 150000003626 triacylglycerols Chemical class 0.000 description 4
- 230000000007 visual effect Effects 0.000 description 4
- 238000005303 weighing Methods 0.000 description 4
- 229920001971 elastomer Polymers 0.000 description 3
- 239000003995 emulsifying agent Substances 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 239000000178 monomer Substances 0.000 description 3
- 239000002674 ointment Substances 0.000 description 3
- 239000004014 plasticizer Substances 0.000 description 3
- 229920000728 polyester Polymers 0.000 description 3
- 229920001451 polypropylene glycol Polymers 0.000 description 3
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 3
- 239000005060 rubber Substances 0.000 description 3
- 229910052710 silicon Inorganic materials 0.000 description 3
- 239000010703 silicon Substances 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 101000904173 Homo sapiens Progonadoliberin-1 Proteins 0.000 description 2
- 229940124041 Luteinizing hormone releasing hormone (LHRH) antagonist Drugs 0.000 description 2
- 102100024028 Progonadoliberin-1 Human genes 0.000 description 2
- 101000996723 Sus scrofa Gonadotropin-releasing hormone receptor Proteins 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 229920004482 WACKER® Polymers 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 239000000556 agonist Substances 0.000 description 2
- 230000002932 anti-schizophrenic effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 229920006237 degradable polymer Polymers 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- XLXSAKCOAKORKW-UHFFFAOYSA-N gonadorelin Chemical compound C1CCC(C(=O)NCC(N)=O)N1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)CNC(=O)C(NC(=O)C(CO)NC(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C(CC=1NC=NC=1)NC(=O)C1NC(=O)CC1)CC1=CC=C(O)C=C1 XLXSAKCOAKORKW-UHFFFAOYSA-N 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 239000003667 hormone antagonist Substances 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 238000011866 long-term treatment Methods 0.000 description 2
- 239000008239 natural water Substances 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 229940127557 pharmaceutical product Drugs 0.000 description 2
- 239000004848 polyfunctional curative Substances 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000011179 visual inspection Methods 0.000 description 2
- 239000004831 Hot glue Substances 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 229920002535 Polyethylene Glycol 1500 Polymers 0.000 description 1
- 229920002556 Polyethylene Glycol 300 Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 210000000080 chela (arthropods) Anatomy 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 229920003052 natural elastomer Polymers 0.000 description 1
- 229920001194 natural rubber Polymers 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 238000001050 pharmacotherapy Methods 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 229920002959 polymer blend Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000012858 resilient material Substances 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 229920003051 synthetic elastomer Polymers 0.000 description 1
- 239000005061 synthetic rubber Substances 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- VUYXVWGKCKTUMF-UHFFFAOYSA-N tetratriacontaethylene glycol monomethyl ether Chemical compound COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO VUYXVWGKCKTUMF-UHFFFAOYSA-N 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- PVNIQBQSYATKKL-UHFFFAOYSA-N tripalmitin Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCC PVNIQBQSYATKKL-UHFFFAOYSA-N 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0069—Devices for implanting pellets, e.g. markers or solid medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/04—Macromolecular materials
- A61L29/06—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
- A61L29/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/34—Trocars; Puncturing needles
- A61B17/3468—Trocars; Puncturing needles for implanting or removing devices, e.g. prostheses, implants, seeds, wires
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Dermatology (AREA)
- Medical Informatics (AREA)
- Anesthesiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Reproductive Health (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Endocrinology (AREA)
- Medicinal Preparation (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102010013898A DE102010013898A1 (de) | 2010-04-01 | 2010-04-01 | Implantatskanüle mit Implantat und Verfahren zum Befestigen von Implantaten in einer Injektionskanüle |
| DE102010013898.3 | 2010-04-01 | ||
| PCT/EP2011/000763 WO2011120608A1 (de) | 2010-04-01 | 2011-02-17 | Implantatskanüle mit implantat und verfahren zum befestigen von implantaten in einer injektionskanüle |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2790257A1 CA2790257A1 (en) | 2011-10-06 |
| CA2790257C true CA2790257C (en) | 2017-12-12 |
Family
ID=43769134
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2790257A Expired - Fee Related CA2790257C (en) | 2010-04-01 | 2011-02-17 | Implant cannula having an implant and method for securing implants in an injection cannula |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US9616212B2 (https=) |
| EP (1) | EP2552468A1 (https=) |
| JP (1) | JP5886826B2 (https=) |
| AU (1) | AU2011234911B2 (https=) |
| CA (1) | CA2790257C (https=) |
| DE (1) | DE102010013898A1 (https=) |
| NZ (1) | NZ601812A (https=) |
| WO (1) | WO2011120608A1 (https=) |
| ZA (1) | ZA201206139B (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015130945A1 (en) | 2014-02-26 | 2015-09-03 | Allergan, Inc. | Intraocular implant delivery apparatus and methods of use thereof |
| JP7665645B2 (ja) * | 2020-03-20 | 2025-04-21 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 局所的な薬物送達のための移植可能な薬物送達デバイス |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB786850A (en) | 1956-08-30 | 1957-11-27 | Foundation Lab Inc | An implanter and cartridge therefor |
| JPS6335261A (ja) * | 1986-07-30 | 1988-02-15 | 住友製薬株式会社 | 製剤投与器 |
| US5002548A (en) | 1986-10-06 | 1991-03-26 | Bio Medic Data Systems, Inc. | Animal marker implanting system |
| US4787384A (en) | 1986-10-06 | 1988-11-29 | Bio Medic Data System, Inc. | Animal marker implanting system |
| DE4320754A1 (de) | 1993-06-23 | 1995-01-05 | Hoechst Ag | Vorrichtung zum Applizieren von Implantaten |
| US20020111603A1 (en) | 1996-12-02 | 2002-08-15 | Societe De Conseils De Recherches Et D'application | Device for local administration of solid or semi-solid formulations and delayed-release formulations for proposal parental administration and preparation process |
| BR9810180A (pt) * | 1997-06-20 | 2000-08-08 | Akzo Nobel Nv | Dispositivo de implantação |
| DE69829086T2 (de) | 1997-12-29 | 2005-12-29 | Alza Corp., Mountain View | Phiole für Implantat |
| DK1300129T3 (da) | 1997-12-29 | 2005-06-20 | Alza Corp | Implantathætteglas |
| US6402677B1 (en) * | 1999-12-17 | 2002-06-11 | C.R. Bard, Inc. | Brachytherapy seed needle with window |
| JP2006520786A (ja) * | 2003-03-14 | 2006-09-14 | シネクサス， インコーポレイテッド | 徐放性治療剤の洞送達 |
| US7481798B2 (en) * | 2003-03-20 | 2009-01-27 | Boston Scientific Scimed, Inc. | Devices and methods for delivering therapeutic or diagnostic agents |
| US7780973B2 (en) * | 2003-12-15 | 2010-08-24 | Ethicon Endo-Surgery, Inc. | Method and device for minimally invasive implantation of biomaterial |
| EP2452670A1 (en) * | 2004-10-01 | 2012-05-16 | Ramscor, Inc. | Conveniently implantable sustained release drug compositions |
| DE102005020078A1 (de) | 2005-04-29 | 2006-11-02 | Novosis Ag | Vorrichtung und Set für Implantate |
| US9301792B2 (en) * | 2006-01-27 | 2016-04-05 | Stryker Corporation | Low pressure delivery system and method for delivering a solid and liquid mixture into a target site for medical treatment |
| US20080294039A1 (en) * | 2006-08-04 | 2008-11-27 | Senorx, Inc. | Assembly with hemostatic and radiographically detectable pellets |
| US9039761B2 (en) | 2006-08-04 | 2015-05-26 | Allergan, Inc. | Ocular implant delivery assemblies with distal caps |
| DE202009016524U1 (de) | 2009-12-04 | 2010-05-12 | Acino Ag | Kanüle und Kanülenvorrichtung zum Implantieren eines Implantats |
-
2010
- 2010-04-01 DE DE102010013898A patent/DE102010013898A1/de not_active Ceased
-
2011
- 2011-02-17 CA CA2790257A patent/CA2790257C/en not_active Expired - Fee Related
- 2011-02-17 EP EP11704195A patent/EP2552468A1/de not_active Withdrawn
- 2011-02-17 WO PCT/EP2011/000763 patent/WO2011120608A1/de not_active Ceased
- 2011-02-17 NZ NZ601812A patent/NZ601812A/en not_active IP Right Cessation
- 2011-02-17 JP JP2013501649A patent/JP5886826B2/ja not_active Expired - Fee Related
- 2011-02-17 US US13/637,672 patent/US9616212B2/en not_active Expired - Fee Related
- 2011-02-17 AU AU2011234911A patent/AU2011234911B2/en not_active Ceased
-
2012
- 2012-08-15 ZA ZA2012/06139A patent/ZA201206139B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20130110077A1 (en) | 2013-05-02 |
| AU2011234911A1 (en) | 2012-10-18 |
| JP2013523229A (ja) | 2013-06-17 |
| EP2552468A1 (de) | 2013-02-06 |
| CA2790257A1 (en) | 2011-10-06 |
| ZA201206139B (en) | 2013-10-30 |
| AU2011234911B2 (en) | 2014-06-05 |
| NZ601812A (en) | 2014-01-31 |
| DE102010013898A1 (de) | 2011-10-06 |
| JP5886826B2 (ja) | 2016-03-16 |
| WO2011120608A1 (de) | 2011-10-06 |
| US9616212B2 (en) | 2017-04-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12138429B2 (en) | Angled syringe patch injector | |
| JP4236874B2 (ja) | 移植装置 | |
| EP2244752B1 (en) | Low viscosity liquid polymeric delivery system | |
| CN108697882B (zh) | 利用生物相容性高分子的微针的制备方法 | |
| MX2014015902A (es) | Suministro de farmaco biodegradable para las composiciones hidrofobicas. | |
| EP2823808A1 (en) | Pharmaceutical composition for a sustained release of lanreotide | |
| US20250049994A1 (en) | Polymer system for securing implants in syringe needles | |
| US20170100543A1 (en) | Angled syringe patch injector | |
| EP3305349B1 (en) | Pharmaceutical cartridge | |
| CA2790257C (en) | Implant cannula having an implant and method for securing implants in an injection cannula | |
| AU2011240364B2 (en) | Cannula device and method and device for providing a cannula device with an implant | |
| CN114191379A (zh) | 以Pluronic F127为载体进行在体局部转基因的修复皮肤损伤药物及制备方法 | |
| KR102484179B1 (ko) | 펩타이드 계열 유효 성분을 포함하는 마이크로 니들 및 이를 제조하기 위한 제형 조성물 | |
| KR20120014248A (ko) | 누점 마개 내로 약제를 분배하기 위한 방법 및 장치 | |
| US20250295903A1 (en) | Microneedle drug delivery devices and methods for using the same | |
| ES2370377T3 (es) | Sistema de administración de un líquido polimérico de baja viscosidad. | |
| HK40027833A (en) | Polymer system for securing implants in syringe needles | |
| HK1255540B (en) | Method for manufacturing microneedle by using biocompatible polymer | |
| HK1255540A1 (en) | Method for manufacturing microneedle by using biocompatible polymer | |
| HK1150982B (en) | Low viscosity liquid polymeric delivery system |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20151001 |
|
| MKLA | Lapsed |
Effective date: 20210217 |